Consun Pharmaceutical Group Ltd (hkse:01681) Share Price

Company Profile

Business description
Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.
Contact
71, Dongpeng Avenue
Eastern section
Guangzhou Economic and Technological Development
Guangzhou
CHN
T: +86 2082264529
https://www.chinaconsun.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
3,164

Recommended

Acquisition unlikely to improve prospects in the US and detracts from other opportunities.

Roy Van Keulen | 15 September 2025

Finding value in an expensive market.

Simonelle Mody | 15 September 2025

Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.

Joseph Taylor | 11 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,120.90	34.10	0.38%
CAC 40	7,895.20	69.96	0.89%
DAX 40	23,733.27	35.12	0.15%
Dow JONES (US)	45,901.56	67.34	0.15%
FTSE 100	9,274.58	8.71	-0.09%
HKSE	26,446.56	58.40	0.22%
NASDAQ	22,301.45	160.35	0.72%
Nikkei 225	44,768.12	395.62	0.89%
NZX 50 Index	13,208.31	19.59	-0.15%
S&P 500	6,615.28	30.99	0.47%
S&P/ASX 200	8,853.00	31.60	0.36%
SSE Composite Index	3,860.50	10.09	-0.26%